查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1460197

體外轉錄模板市場（疾病：癌症、傳染病、生活方式疾病、遺傳疾病等；以及治療：疫苗和治療）- 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

In-vitro Transcription Templates Market (Disease: Cancer, Infectious Diseases, Lifestyle Diseases, Genetic Diseases, and Others; and Treatment: Vaccine and Therapeutic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 233 Pages | 商品交期: 2-10個工作天內

價格

體外轉錄模板市場 - 報告範圍

TMR 關於全球體外轉錄模板市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球體外轉錄模板市場的收入-2017- 2031年期間的體外轉錄模板市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球體外轉錄模板市場的年複合成長率（CAGR %）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解體外轉錄模板市場。

市場概況
2022年市場價​​值 2.316 億美元
2031 年市場價值 12億美元
CAGR 20%

該報告深入研究了全球體外轉錄模板市場的競爭格局。全球體外轉錄模板市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球體外轉錄範本市場參與者的屬性。

目錄

第1章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 管道分析
  • 主要產品/品牌分析
  • 主要併購
  • COVID-19 大流行對該行業的影響

第 6 章：全球市場分析與預測：依疾病分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依疾病分類，2017-2031
    • 癌症
      • 實體腫瘤
      • 大腸直腸癌
      • 非小細胞肺癌
      • 黑色素瘤
      • 白血病
      • 攝護腺癌
      • 其他
    • 傳染性疾病
      • 流感
      • 新冠肺炎
      • 愛滋病
      • 其他
    • 生活方式疾病
    • 遺傳疾病
    • 其他
  • 市場吸引力：依疾病分類

第 7 章：全球市場分析與預測：按處理方式

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依處理方式，2017-2031
    • 疫苗
    • 治療性
    • 7.4 市場吸引力：按待遇

第 8 章：全球市場分析與預測：依研究階段分類

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：依研究階段，2017-2031
    • 探索性
    • 臨床
  • 市場吸引力：依研究階段分類

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介和定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 製藥與生物技術公司
    • CRO 和 CMO
    • 學術與研究
    • 其他
  • 市場吸引力：按最終用戶分類

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力：按地區

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2022 年）
  • 公司簡介
    • Thermo Fisher Scientific Inc.
    • Promega Corporation
    • Agilent Technologies, Inc.
    • New England Biolabs
    • Takara Bio Inc.
    • LGC Limited
    • Enzynomics Co. Ltd.
    • Enzo Life Sciences, Inc.
    • Danaher Corporation
Product Code: TMRGL43415

In-vitro Transcription Templates Market - Scope of Report

TMR's report on the global in-vitro transcription templates market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global in-vitro transcription templates market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in-vitro transcription templates market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the in-vitro transcription templates market.

Market Snapshot
Market Value in 2022US$ 231.6 Mn
Market Value in 2031US$ 1.2 Bn
CAGR20%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in-vitro transcription templates market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in-vitro transcription templates market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in-vitro transcription templates market.

The report delves into the competitive landscape of the global in-vitro transcription templates market. Key players operating in the global in-vitro transcription templates market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in-vitro transcription templates market profiled in this report.

Key Questions Answered in Global in-vitro transcription templates Market Report:

  • What is the sales/revenue generated by in-vitro transcription templates across all regions during the forecast period?
  • What are the opportunities in the global in-vitro transcription templates market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

In-vitro Transcription Templates Market - Research Objectives and Research Approach

The comprehensive report on the global in-vitro transcription templates market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global in-vitro transcription templates market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in-vitro transcription templates market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global In-vitro Transcription Templates Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global In-vitro Transcription Templates Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global In-vitro Transcription Templates Market Analysis and Forecast, by Disease

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Disease, 2017-2031
    • 6.3.1. Cancer
      • 6.3.1.1. Solid Tumors
      • 6.3.1.2. Colorectal Cancer
      • 6.3.1.3. NSCLC
      • 6.3.1.4. Melanoma
      • 6.3.1.5. Leukemia
      • 6.3.1.6. Prostate Cancer
      • 6.3.1.7. Others
    • 6.3.2. Infectious Diseases
      • 6.3.2.1. Influenza
      • 6.3.2.2. COVID-19
      • 6.3.2.3. AIDS
      • 6.3.2.4. Others
    • 6.3.3. Lifestyle Diseases
    • 6.3.4. Genetic Diseases
    • 6.3.5. Others
  • 6.4. Market Attractiveness, by Disease

7. Global In-vitro Transcription Templates Market Analysis and Forecast, by Treatment

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Treatment, 2017-2031
    • 7.3.1. Vaccine
    • 7.3.2. Therapeutic
    • 7.3.3. 7.4 Market Attractiveness, by Treatment

8. Global In-vitro Transcription Templates Market Analysis and Forecast, by Research Stage

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Research Stage, 2017-2031
    • 8.3.1. Exploratory
    • 8.3.2. Clinical
  • 8.4. Market Attractiveness, by Research Stage

9. Global In-vitro Transcription Templates Market Analysis and Forecast, by End-user

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical & Biotechnology Companies
    • 9.3.2. CROs & CMOs
    • 9.3.3. Academics & Research
    • 9.3.4. Others
  • 9.4. Market Attractiveness, by End-user

10. Global In-vitro Transcription Templates Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America In-vitro Transcription Templates Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Disease, 2017-2031
    • 11.2.1. Cancer
      • 11.2.1.1. Solid Tumors
      • 11.2.1.2. Colorectal Cancer
      • 11.2.1.3. NSCLC
      • 11.2.1.4. Melanoma
      • 11.2.1.5. Leukemia
      • 11.2.1.6. Prostate Cancer
      • 11.2.1.7. Others
    • 11.2.2. Infectious Diseases
      • 11.2.2.1. Influenza
      • 11.2.2.2. COVID-19
      • 11.2.2.3. AIDS
      • 11.2.2.4. Others
    • 11.2.3. Lifestyle Diseases
    • 11.2.4. Genetic Diseases
    • 11.2.5. Others
  • 11.3. Market Attractiveness, by Disease
  • 11.4. Market Value Forecast, by Treatment, 2017-2031
    • 11.4.1. Vaccine
    • 11.4.2. Therapeutic
  • 11.5. Market Attractiveness, by Treatment
  • 11.6. Market Value Forecast, by Research Stage, 2017-2031
    • 11.6.1. Exploratory
    • 11.6.2. Clinical
  • 11.7. Market Attractiveness, by Research Stage
  • 11.8. Market Value Forecast, by End-user, 2017-2031
    • 11.8.1. Pharmaceutical & Biotechnology Companies
    • 11.8.2. CROs & CMOs
    • 11.8.3. Academics & Research
    • 11.8.4. Others
  • 11.9. Market Attractiveness, by End-user
  • 11.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Disease
    • 11.11.2. By Treatment
    • 11.11.3. By Research Stage
    • 11.11.4. By End-user
    • 11.11.5. By Country

12. Europe In-vitro Transcription Templates Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Disease, 2017-2031
    • 12.2.1. Cancer
      • 12.2.1.1. Solid Tumors
      • 12.2.1.2. Colorectal Cancer
      • 12.2.1.3. NSCLC
      • 12.2.1.4. Melanoma
      • 12.2.1.5. Leukemia
      • 12.2.1.6. Prostate Cancer
      • 12.2.1.7. Others
    • 12.2.2. Infectious Diseases
      • 12.2.2.1. Influenza
      • 12.2.2.2. COVID-19
      • 12.2.2.3. AIDS
      • 12.2.2.4. Others
    • 12.2.3. Lifestyle Diseases
    • 12.2.4. Genetic Diseases
    • 12.2.5. Others
  • 12.3. Market Attractiveness, by Disease
  • 12.4. Market Value Forecast, by Treatment, 2017-2031
    • 12.4.1. Vaccine
    • 12.4.2. Therapeutic
  • 12.5. Market Attractiveness, by Treatment
  • 12.6. Market Value Forecast, by Research Stage, 2017-2031
    • 12.6.1. Exploratory
    • 12.6.2. Clinical
  • 12.7. Market Attractiveness, by Research Stage
  • 12.8. Market Value Forecast, by End-user, 2017-2031
    • 12.8.1. Pharmaceutical & Biotechnology Companies
    • 12.8.2. CROs & CMOs
    • 12.8.3. Academics & Research
    • 12.8.4. Others
  • 12.9. Market Attractiveness, by End-user
  • 12.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Disease
    • 12.11.2. By Treatment
    • 12.11.3. By Research Stage
    • 12.11.4. By End-user
    • 12.11.5. By Country/Sub-region

13. Asia Pacific In-vitro Transcription Templates Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Disease, 2017-2031
    • 13.2.1. Cancer
      • 13.2.1.1. Solid Tumors
      • 13.2.1.2. Colorectal Cancer
      • 13.2.1.3. NSCLC
      • 13.2.1.4. Melanoma
      • 13.2.1.5. Leukemia
      • 13.2.1.6. Prostate Cancer
      • 13.2.1.7. Others
    • 13.2.2. Infectious Diseases
      • 13.2.2.1. Influenza
      • 13.2.2.2. COVID-19
      • 13.2.2.3. AIDS
      • 13.2.2.4. Others
    • 13.2.3. Lifestyle Diseases
    • 13.2.4. Genetic Diseases
    • 13.2.5. Others
  • 13.3. Market Attractiveness, by Disease
  • 13.4. Market Value Forecast, by Treatment, 2017-2031
    • 13.4.1. Vaccine
    • 13.4.2. Therapeutic
  • 13.5. Market Attractiveness, by Treatment
  • 13.6. Market Value Forecast, by Research Stage, 2017-2031
    • 13.6.1. Exploratory
    • 13.6.2. Clinical
  • 13.7. Market Attractiveness, by Research Stage
  • 13.8. Market Value Forecast, by End-user, 2017-2031
    • 13.8.1. Pharmaceutical & Biotechnology Companies
    • 13.8.2. CROs & CMOs
    • 13.8.3. Academics & Research
    • 13.8.4. Others
  • 13.9. Market Attractiveness, by End-user
  • 13.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Disease
    • 13.11.2. By Treatment
    • 13.11.3. By Research Stage
    • 13.11.4. By End-user
    • 13.11.5. By Country/Sub-region

14. Latin America In-vitro Transcription Templates Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Disease, 2017-2031
    • 14.2.1. Cancer
      • 14.2.1.1. Solid Tumors
      • 14.2.1.2. Colorectal Cancer
      • 14.2.1.3. NSCLC
      • 14.2.1.4. Melanoma
      • 14.2.1.5. Leukemia
      • 14.2.1.6. Prostate Cancer
      • 14.2.1.7. Others
    • 14.2.2. Infectious Diseases
      • 14.2.2.1. Influenza
      • 14.2.2.2. COVID-19
      • 14.2.2.3. AIDS
      • 14.2.2.4. Others
    • 14.2.3. Lifestyle Diseases
    • 14.2.4. Genetic Diseases
    • 14.2.5. Others
  • 14.3. Market Attractiveness, by Disease
  • 14.4. Market Value Forecast, by Treatment, 2017-2031
    • 14.4.1. Vaccine
    • 14.4.2. Therapeutic
  • 14.5. Market Attractiveness, by Treatment
  • 14.6. Market Value Forecast, by Research Stage, 2017-2031
    • 14.6.1. Exploratory
    • 14.6.2. Clinical
  • 14.7. Market Attractiveness, by Research Stage
  • 14.8. Market Value Forecast, by End-user, 2017-2031
    • 14.8.1. Pharmaceutical & Biotechnology Companies
    • 14.8.2. CROs & CMOs
    • 14.8.3. Academics & Research
    • 14.8.4. Others
  • 14.9. Market Attractiveness, by End-user
  • 14.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Disease
    • 14.11.2. By Treatment
    • 14.11.3. By Research Stage
    • 14.11.4. By End-user
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa In-vitro Transcription Templates Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Disease, 2017-2031
    • 15.2.1. Cancer
      • 15.2.1.1. Solid Tumors
      • 15.2.1.2. Colorectal Cancer
      • 15.2.1.3. NSCLC
      • 15.2.1.4. Melanoma
      • 15.2.1.5. Leukemia
      • 15.2.1.6. Prostate Cancer
      • 15.2.1.7. Others
    • 15.2.2. Infectious Diseases
      • 15.2.2.1. Influenza
      • 15.2.2.2. COVID-19
      • 15.2.2.3. AIDS
      • 15.2.2.4. Others
    • 15.2.3. Lifestyle Diseases
    • 15.2.4. Genetic Diseases
    • 15.2.5. Others
  • 15.3. Market Attractiveness, by Disease
  • 15.4. Market Value Forecast, by Treatment, 2017-2031
    • 15.4.1. Vaccine
    • 15.4.2. Therapeutic
  • 15.5. Market Attractiveness, by Treatment
  • 15.6. Market Value Forecast, by Research Stage, 2017-2031
    • 15.6.1. Exploratory
    • 15.6.2. Clinical
  • 15.7. Market Attractiveness, by Research Stage
  • 15.8. Market Value Forecast, by End-user, 2017-2031
    • 15.8.1. Pharmaceutical & Biotechnology Companies
    • 15.8.2. CROs & CMOs
    • 15.8.3. Academics & Research
    • 15.8.4. Others
  • 15.9. Market Attractiveness, by End-user
  • 15.10. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Disease
    • 15.11.2. By Treatment
    • 15.11.3. By Research Stage
    • 15.11.4. By End-user
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2022)
  • 16.3. Company Profiles
    • 16.3.1. Thermo Fisher Scientific Inc.
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Promega Corporation
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Agilent Technologies, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. New England Biolabs
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Takara Bio Inc.
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. LGC Limited
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Enzynomics Co. Ltd.
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Enzo Life Sciences, Inc.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Danaher Corporation
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview

List of Tables

  • Table 01: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 02: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 03: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 04: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 05: Global In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 08: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 9: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 10: North America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 13: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 14: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 15: Europe In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 18: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 19: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 20: Asia Pacific In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 23: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 24: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 25: Latin America In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Disease, 2017-2031
  • Table 28: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Treatment, 2017-2031
  • Table 29: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by Research Stage, 2017-2031
  • Table 30: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global In-vitro Transcription Templates Market Size (US$ Mn), by Region, 2022-2031
  • Figure 02: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Disease, 2022
  • Figure 03: Global In-vitro Transcription Templates Market Value Share, by Disease, 2022
  • Figure 04: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Treatment, 2022
  • Figure 05: Global In-vitro Transcription Templates Market Value Share, by Treatment, 2022
  • Figure 06: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by Research Stage, 2022
  • Figure 07: Global In-vitro Transcription Templates Market Value Share, by Research Stage, 2022
  • Figure 08: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 09: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 10: Global In-vitro Transcription Templates Market Value Share, by Region, 2022
  • Figure 11: Global In-vitro Transcription Templates Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 12: Global In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 13: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 14: Global In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 15: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 16: Global In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 17: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 18: Global In-vitro Transcription Templates Market Revenue (US$ Mn), by End-user, 2022
  • Figure 19: Global In-vitro Transcription Templates Market Value Share, by End-user, 2022
  • Figure 20: Global In-vitro Transcription Templates Market Value Share Analysis, by Region, 2022-2031
  • Figure 21: Global In-vitro Transcription Templates Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 23: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 24: North America In-vitro Transcription Templates Market Value Share Analysis, by Country, 2022-2031
  • Figure 25: North America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 26: North America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 27: North America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 28: North America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 29: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 30: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 31: North America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 32: North America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 33: Europe In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 34: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 36: Europe In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 37: Europe In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 38: Europe In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 39: Europe In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 40: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 41: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 42: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 43: Europe In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 44: Asia Pacific In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 45: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 46: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 47: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 48: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 49: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 50: Asia Pacific In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 51: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 52: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 53: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 54: Asia Pacific In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 55: Latin America In-vitro Transcription Templates Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 56: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 57: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 59: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 60: Latin America In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 61: Latin America In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 62: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 63: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 64: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 65: Latin America In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 66: Middle East & Africa In-vitro Transcription Templates Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017-2031
  • Figure 67: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 68: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Country/Sub-region, 2022-2031
  • Figure 69: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Disease, 2022-2031
  • Figure 70: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Treatment, 2022-2031
  • Figure 71: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by Research Stage, 2022-2031
  • Figure 72: Middle East & Africa In-vitro Transcription Templates Market Value Share Analysis, by End-user, 2022-2031
  • Figure 73: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Disease, 2023-2031
  • Figure 74: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Treatment, 2023-2031
  • Figure 75: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by Research Stage, 2023-2031
  • Figure 76: Middle East & Africa In-vitro Transcription Templates Market Attractiveness Analysis, by End-user, 2023-2031